AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15067650 — intervention group
Group type: COMPARATOR
Intervention: Posterior Cruciate-Retaining (PCR) TKA
Number of subjects: 20
Study 11130216 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram 10 mg once/day for the first week, 20 mg once/day for the second week, and 40 mg once/day for the remaining 3 weeks
Number of subjects: 32
Study 11130216 — intervention group
Group type: COMPARATOR
Intervention: Citalopram
Number of subjects: 32
Study 9050976 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg moxonidine once a day (increased to 0.4 mg after 2 weeks)
Number of subjects: 140
Study 9050976 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg enalapril once a day (increased to 10 mg after 2 weeks)
Number of subjects: 140
Study 9050976 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 8319334 — intervention group
Group type: EXPERIMENTAL
Intervention: Colestipol-niacin therapy
Number of subjects: 78
Study 8319334 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 3539617 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol administered over 12 hours by continuous infusion at three different rates
Number of subjects: 20
Study 3539617 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline infusion)
Number of subjects: 20
Study 30325784 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral catheter removal 6 hours postoperative
Number of subjects: 88
Study 30325784 — intervention group
Group type: COMPARATOR
Intervention: Transurethral catheter removal the morning following surgery (control group)
Number of subjects: 88
Study 30325784 — intervention group
Group type: COMPARATOR
Intervention: Control group (morning following surgery)
Number of subjects: 88
Study 29948418 — intervention group
Group type: EXPERIMENTAL
Intervention: TachoSil® patches
Number of subjects: 142
Study 29948418 — intervention group
Group type: COMPARATOR
Intervention: Control group (no TachoSil®)
Number of subjects: 142
Study 27560495 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal triglycerides in late pregnancy
Number of subjects: 331
Study 27560495 — intervention group
Group type: EXPERIMENTAL
Intervention: Cord blood triglycerides
Number of subjects: 331
Study 27560495 — intervention group
Group type: EXPERIMENTAL
Intervention: Cord HDL‐C
Number of subjects: 331
Study 23905590 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 30
Study 23905590 — intervention group
Group type: COMPARATOR
Intervention: Behaviour Therapy (BT)
Number of subjects: 30
Study 22086903 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted gait training (n = 20), 40 minutes of gait training with Lokomat and 60 minutes of conventional physical therapy daily.
Number of subjects: 37
Study 22086903 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy (n = 17), 100 minutes of conventional physical therapy daily.
Number of subjects: 37
Study 20592268 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper-limb exercise with caregiver support
Number of subjects: 50
Study 20592268 — intervention group
Group type: COMPARATOR
Intervention: Upper-limb exercise without caregiver support
Number of subjects: 50
Study 20592268 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver support
Number of subjects: 50
Study 20592268 — intervention group
Group type: EXPERIMENTAL
Intervention: Fugl-Meyer score and treatment intensity
Number of subjects: 50
Study 17917464 — intervention group
Group type: EXPERIMENTAL
Intervention: Bladder training alone
Number of subjects: 48
Study 17917464 — intervention group
Group type: EXPERIMENTAL
Intervention: Propiverine combined with bladder training
Number of subjects: 48
Study 16043733 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled insulin (INH) before meals
Number of subjects: 145
Study 16043733 — intervention group
Group type: COMPARATOR
Intervention: Rosiglitazone 4 mg twice a day
Number of subjects: 145
Study 12439133 — intervention group
Group type: EXPERIMENTAL
Intervention: Test weight group (weighing infants before and after breastfeeding)
Number of subjects: 60
Study 12439133 — intervention group
Group type: COMPARATOR
Intervention: Nontest weight group (no weighing before and after breastfeeding)
Number of subjects: 60
Study 10048638 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan/copolymer/fluoride-containing dentifrice
Number of subjects: 60
Study 10048638 — intervention group
Group type: COMPARATOR
Intervention: Placebo dentifrice
Number of subjects: 60
Study 8615554 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (two doses) with paracetamol
Number of subjects: 629
Study 8615554 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol alone
Number of subjects: 629
Study 8615554 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine with paracetamol
Number of subjects: 629
Study 1679658 — intervention group
Group type: EXPERIMENTAL
Intervention: Terfenadine (H1-selective histamine antagonist)
Number of subjects: 0
Study 1679658 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound 48/80 (histamine depleting agent)
Number of subjects: 0
Study 1679658 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal PAF injection
Number of subjects: 0
Study 1679658 — intervention group
Group type: COMPARATOR
Intervention: Baseline plasma histamine levels
Number of subjects: 0
Study 7006883 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol 10 to 30 mg twice daily
Number of subjects: 8
Study 7006883 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 31763982 — intervention group
Group type: EXPERIMENTAL
Intervention: Final kissing balloon inflation (FKBI) after PCI
Number of subjects: 948
Study 31763982 — intervention group
Group type: COMPARATOR
Intervention: No final kissing balloon inflation (FKBI) after PCI
Number of subjects: 948
Study 31311922 — intervention group
Group type: EXPERIMENTAL
Intervention: Zwitterionic near-infrared fluorophore ZW800-1
Number of subjects: 0
Study 28834253 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg NaHED (Study I)
Number of subjects: 27
Study 28834253 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg NaHED with 75 g glucose (Study II)
Number of subjects: 27
Study 28834253 — intervention group
Group type: COMPARATOR
Intervention: Control (no NaHED)
Number of subjects: 27
Study 26284723 — intervention group
Group type: COMPARATOR
Intervention: 8 weeks nicotine patch treatment
Number of subjects: 525
Study 26284723 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 weeks nicotine patch treatment
Number of subjects: 525
Study 26284723 — intervention group
Group type: EXPERIMENTAL
Intervention: 52 weeks nicotine patch treatment
Number of subjects: 525
Study 26284723 — intervention group
Group type: COMPARATOR
Intervention: Extended treatment (24 weeks)
Number of subjects: 525
Study 26284723 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (8 weeks)
Number of subjects: 525
Study 23560519 — intervention group
Group type: EXPERIMENTAL
Intervention: Active TCPRFT
Number of subjects: 51
Study 23560519 — intervention group
Group type: COMPARATOR
Intervention: Sham TCPRFT
Number of subjects: 51
Study 22945761 — intervention group
Group type: EXPERIMENTAL
Intervention: Bazedoxifene (20 or 40 mg)
Number of subjects: 5244
Study 19241364 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic 80 bpm intra‐aortic balloon pump (IABP) induced pulsatile CPB (Group B)
Number of subjects: 158
Study 18201586 — intervention group
Group type: EXPERIMENTAL
Intervention: IV iron supplementation (1 g IV iron sucrose administered as a 100 mg dose at each of 10 consecutive HD sessions)
Number of subjects: 12
Study 18201586 — intervention group
Group type: EXPERIMENTAL
Intervention: IV iron supplementation in a subgroup of 7 HD patients with low baseline CYP3A4 activity
Number of subjects: 12
Study 18201586 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (7 age-, sex-, and race-matched individuals)
Number of subjects: 12
Study 15288482 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha 2a 3MIU thrice weekly with ribavirin 800-1,000 mg/day
Number of subjects: 80
Study 15288482 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha 2a 3MIU daily plus amantadine 200 mg/day with ribavirin 800-1,000 mg/day
Number of subjects: 80
Study 15288482 — intervention group
Group type: COMPARATOR
Intervention: Both groups (A and B)
Number of subjects: 80
Study 11713358 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic treatment for purulent sputum (5 or 10 days)
Number of subjects: 63
Study 11713358 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose inhaled steroid (fluticasone) for mucoid sputum (14 days)
Number of subjects: 63
Study 11713358 — intervention group
Group type: COMPARATOR
Intervention: Placebo for mucoid sputum (14 days)
Number of subjects: 63
Study 9393423 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine digluconate rinses
Number of subjects: 595
Study 9393423 — intervention group
Group type: COMPARATOR
Intervention: Control (no chlorhexidine)
Number of subjects: 595
Study 7961584 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine (mean dose 5.99 ± 2.6 mg/kg/day for 6 weeks)
Number of subjects: 11
Study 7961584 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol (mean dose 0.24 ± 0.20 mg/kg/day for 6 weeks)
Number of subjects: 11
Study 3330986 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinacidil (64.3 mg/day for 8.5 weeks)
Number of subjects: 29
Study 3330986 — intervention group
Group type: COMPARATOR
Intervention: Hydralazine (163.3 mg/day for 8.3 weeks)
Number of subjects: 29
Study 3330986 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinacidil and Hydralazine (both treatments)
Number of subjects: 29
Study 30648879 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive and behavioral treatment (CBT)
Number of subjects: 47
Study 30648879 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive and behavioral treatment supported by the ETIOBE web platform
Number of subjects: 47
Study 29082794 — intervention group
Group type: EXPERIMENTAL
Intervention: Initiation of breastfeeding after birth
Number of subjects: 1679
Study 29082794 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusive breastfeeding
Number of subjects: 1679
Study 29082794 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula feeding
Number of subjects: 1679
Study 25794112 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermia with xenon
Number of subjects: 32
Study 25794112 — intervention group
Group type: COMPARATOR
Intervention: Hypothermia only
Number of subjects: 32
Study 23506344 — intervention group
Group type: EXPERIMENTAL
Intervention: Human fibroblast-derived dermal substitute (HFDS) plus four-layer compression therapy
Number of subjects: 366
Study 23506344 — intervention group
Group type: COMPARATOR
Intervention: Compression therapy alone (Control)
Number of subjects: 366
Study 23506344 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events (AEs)
Number of subjects: 366
Study 21199975 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive behavior therapy (TF-CBT)
Number of subjects: 124
Study 21199975 — intervention group
Group type: COMPARATOR
Intervention: Usual care (child-centered therapy)
Number of subjects: 124
Study 19934803 — intervention group
Group type: EXPERIMENTAL
Intervention: DC electrical stimulation
Number of subjects: 107
Study 19934803 — intervention group
Group type: COMPARATOR
Intervention: Control (no DC electrical stimulation)
Number of subjects: 107
Study 16908310 — intervention group
Group type: EXPERIMENTAL
Intervention: Histidine-tryptophan-ketoglutarate (HTK) solution
Number of subjects: 102
Study 16908310 — intervention group
Group type: COMPARATOR
Intervention: University of Wisconsin (UW) solution
Number of subjects: 102
Study 15005595 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantec Spinal Image System (QSIS) with 3 scans and 1 measurement
Number of subjects: 200
Study 15005595 — intervention group
Group type: COMPARATOR
Intervention: Quantec Spinal Image System (QSIS) with 1 scan
Number of subjects: 200
Study 11575413 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (fentanyl 10-15 microg kg(‐1) and propofol 2-6 mg kg(‐1) intraoperatively and a propofol infusion for 3 h postoperatively)
Number of subjects: 78
Study 11575413 — intervention group
Group type: COMPARATOR
Intervention: Lorazepam followed by midazolam (fentanyl 10-15 microg kg(‐1) and midazolam 0.05-0.075 mg kg(‐1) intraoperatively and a midazolam infusion for 3 h postoperatively)
Number of subjects: 78
Study 11575413 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 78
Study 9512847 — intervention group
Group type: EXPERIMENTAL
Intervention: Oesophageal Doppler monitor (ODM)
Number of subjects: 18
Study 9512847 — intervention group
Group type: COMPARATOR
Intervention: Thermodilution technique
Number of subjects: 18
Study 7527161 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium antagonists (verapamil, nifedipine, verapamil+nifedipine)
Number of subjects: 329
Study 7527161 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol hydrochloride
Number of subjects: 329
Study 7527161 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 329
Study 2920535 — intervention group
Group type: EXPERIMENTAL
Intervention: 94 mg of iron per day as ferrous sulphate with multivitamins
Number of subjects: 0
Study 2920535 — intervention group
Group type: COMPARATOR
Intervention: Placebo of multivitamins without iron
Number of subjects: 0
Study 5575973 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone 300
Number of subjects: 30
Study 5575973 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 30
Study 30875743 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-Assisted Eccentric Contraction Training
Number of subjects: 11
Study 30875743 — intervention group
Group type: COMPARATOR
Intervention: Control Phase
Number of subjects: 11
Study 27999052 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim/sulfamethoxazole
Number of subjects: 81
Study 27999052 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 81
Study 25719718 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluteal augmentation with silicone implants
Number of subjects: 0
Study 23262939 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcine dermis
Number of subjects: 115
Study 23262939 — intervention group
Group type: COMPARATOR
Intervention: Polypropylene mesh
Number of subjects: 115
Study 21425063 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative nasal packing
Number of subjects: 2
Study 21425063 — intervention group
Group type: COMPARATOR
Intervention: No postoperative nasal packing
Number of subjects: 2
Study 18842313 — intervention group
Group type: EXPERIMENTAL
Intervention: Single metronome synchronization (synchronized maximal flexion of the right arm)
Number of subjects: 0
Study 18842313 — intervention group
Group type: EXPERIMENTAL
Intervention: Double metronome within-limb synchronization (synchronized both flexion and extension of the right arm)
Number of subjects: 0
Study 18842313 — intervention group
Group type: EXPERIMENTAL
Intervention: Double metronome between-limb synchronization (synchronized flexion of each arm)
Number of subjects: 0
Study 18842313 — intervention group
Group type: EXPERIMENTAL
Intervention: Different metronome synchronization strategies
Number of subjects: 0
Study 17268167 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative monitoring for embolic signals (ES) using transcranial Doppler (TCD)
Number of subjects: 141
Study 14727224 — intervention group
Group type: EXPERIMENTAL
Intervention: Smallpox vaccine
Number of subjects: 28
Study 11516803 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone 2.5mg daily for 3 months
Number of subjects: 38
Study 11516803 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 9494064 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg (steady state)
Number of subjects: 0
Study 9494064 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 40 mg (steady state)
Number of subjects: 0
Study 9494064 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological in vitro experiments with pantoprazole
Number of subjects: 0
Study 7529921 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte growth factor
Number of subjects: 16
Study 7529921 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 3056499 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed suction wound drainage
Number of subjects: 0
Study 3056499 — intervention group
Group type: COMPARATOR
Intervention: Routine drainage (control)
Number of subjects: 0
Study 30554193 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplement of 4,000 IU daily for 3 years
Number of subjects: 161
Study 30554193 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161
Study 29149865 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery (CRS) + hyperthermic intra‐operative peritoneal chemotherapy (HIPC) with cisplatin
Number of subjects: 32
Study 26778391 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal toothpaste (Sudantha®)
Number of subjects: 80
Study 26778391 — intervention group
Group type: COMPARATOR
Intervention: Placebo toothpaste
Number of subjects: 80
Study 23479153 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional Intervention (NI)
Number of subjects: 82
Study 23479153 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional Intervention and Exercise Practice (NIE)
Number of subjects: 82
Study 22041349 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithrombotic agents
Number of subjects: 6
Study 22041349 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole
Number of subjects: 6
Study 22041349 — intervention group
Group type: EXPERIMENTAL
Intervention: Urokinase
Number of subjects: 6
Study 22041349 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 6
Study 19050988 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedside + Booster
Number of subjects: 90
Study 19050988 — intervention group
Group type: EXPERIMENTAL
Intervention: Faxed Referral
Number of subjects: 90
Study 19050988 — intervention group
Group type: COMPARATOR
Intervention: Standard Referral
Number of subjects: 90
Study 16595246 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate day triptorelin administration
Number of subjects: 0
Study 16595246 — intervention group
Group type: COMPARATOR
Intervention: Daily triptorelin administration
Number of subjects: 0
Study 16424845 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-enriched warm blood cardioplegia (IWBC) (10 UI/L)
Number of subjects: 268
Study 16424845 — intervention group
Group type: COMPARATOR
Intervention: Warm blood cardioplegia (Control group)
Number of subjects: 268
Study 15190658 — intervention group
Group type: EXPERIMENTAL
Intervention: Size 3 LMA
Number of subjects: 135
Study 15190658 — intervention group
Group type: EXPERIMENTAL
Intervention: Size 4 LMA
Number of subjects: 135
Study 15190658 — intervention group
Group type: EXPERIMENTAL
Intervention: Size 5 LMA
Number of subjects: 135
Study 10416302 — intervention group
Group type: EXPERIMENTAL
Intervention: Open laparoscopy
Number of subjects: 253
Study 10416302 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopy
Number of subjects: 253
Study 8528638 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotherapy with IL‐2 and LAK cells
Number of subjects: 105
Study 8528638 — intervention group
Group type: COMPARATOR
Intervention: Standard postoperative radiation therapy or chemotherapy (control group)
Number of subjects: 105
Study 2305009 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (MLT)
Number of subjects: 20
Study 2305009 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 6775300 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin microcapsule preparation 2.5 mg
Number of subjects: 15
Study 6775300 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin microcapsule preparation 7.5 mg
Number of subjects: 15
Study 29334040 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTXA)
Number of subjects: 12
Study 29334040 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 27693759 — intervention group
Group type: EXPERIMENTAL
Intervention: SHINE intervention with added case management and group outings into nature
Number of subjects: 0
Study 27693759 — intervention group
Group type: COMPARATOR
Intervention: Standard care with pediatrician's recommendation to visit parks and written resources (park prescription)
Number of subjects: 0
Study 25016261 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral immune nutrition (EIN group)
Number of subjects: 60
Study 25016261 — intervention group
Group type: COMPARATOR
Intervention: Conventional enteral nutrition (EN group)
Number of subjects: 60
Study 22449296 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 4752
Study 22449296 — intervention group
Group type: COMPARATOR
Intervention: On-pump CABG
Number of subjects: 4752
Study 20370813 — intervention group
Group type: COMPARATOR
Intervention: Teacher-directed, classroom-based programme of physical exercise for 15 minutes, delivered approximately 30 minutes after lunch during one week.
Number of subjects: 1224
Study 20370813 — intervention group
Group type: COMPARATOR
Intervention: No exercise programme during the other week (control group).
Number of subjects: 1224
Study 18306246 — intervention group
Group type: EXPERIMENTAL
Intervention: Short pulse carbon dioxide laser
Number of subjects: 12
Study 18306246 — intervention group
Group type: COMPARATOR
Intervention: Colorado needle with electrocautery
Number of subjects: 12
Study 17342879 — intervention group
Group type: EXPERIMENTAL
Intervention: High dairy meal (500 mg Ca+2)
Number of subjects: 2
Study 17342879 — intervention group
Group type: COMPARATOR
Intervention: Low dairy meal (80 mg Ca+2)
Number of subjects: 2
Study 12827327 — intervention group
Group type: EXPERIMENTAL
Intervention: SWL in situ (group 1)
Number of subjects: 130
Study 12827327 — intervention group
Group type: EXPERIMENTAL
Intervention: SWL after manipulation (group 2)
Number of subjects: 130
Study 10945081 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Number of subjects: 34
Study 10945081 — intervention group
Group type: COMPARATOR
Intervention: Recreational activities and support (ATY)
Number of subjects: 34
Study 9222387 — intervention group
Group type: EXPERIMENTAL
Intervention: Lysine Clonixinate (LC)
Number of subjects: 24
Study 9222387 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 24